AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.
Insider & Institutional Ownership
91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares AirSculpt Technologies and Clover Health Investments”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AirSculpt Technologies | $150.72 million | 0.32 | -$11.67 million | ($0.13) | -5.19 |
| Clover Health Investments | $1.92 billion | 1.34 | -$85.55 million | $0.01 | 483.70 |
AirSculpt Technologies has higher earnings, but lower revenue than Clover Health Investments. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for AirSculpt Technologies and Clover Health Investments, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AirSculpt Technologies | 1 | 1 | 1 | 0 | 2.00 |
| Clover Health Investments | 1 | 3 | 3 | 0 | 2.29 |
AirSculpt Technologies presently has a consensus price target of $3.75, indicating a potential upside of 455.56%. Clover Health Investments has a consensus price target of $5.10, indicating a potential upside of 5.44%. Given AirSculpt Technologies’ higher probable upside, equities analysts clearly believe AirSculpt Technologies is more favorable than Clover Health Investments.
Risk & Volatility
AirSculpt Technologies has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.52, meaning that its stock price is 152% more volatile than the S&P 500.
Profitability
This table compares AirSculpt Technologies and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AirSculpt Technologies | -6.36% | -9.63% | -4.92% |
| Clover Health Investments | 0.45% | 4.83% | 2.53% |
Summary
Clover Health Investments beats AirSculpt Technologies on 10 of the 14 factors compared between the two stocks.
About AirSculpt Technologies
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
